Suppr超能文献

感染HIV-1的患者外周血单个核细胞中血浆病毒载量、病毒DNA和mRNA负荷的变化。

Change in plasma viral load, and viral DNA and mRNA burdens, in peripheral blood mononuclear cells from patients infected with HIV-1.

作者信息

Fujii T, Kato Y, Takata N, Kimura A

机构信息

Division of Blood Transfusion Services, Hiroshima University Medical Hospital, Japan.

出版信息

J Infect. 2001 Jan;42(1):20-6. doi: 10.1053/jinf.2000.0760.

Abstract

OBJECTIVES

To clarify the virological state of human immunodeficiency virus (HIV)-1-infected patients, we compared the plasma HIV-1 RNA copy number (plasma viral load (VL)), viral DNA and mRNA burdens in peripheral blood mononuclear cells (PBMCs), and the other clinical predictors.

METHODS

One hundred and thirty-one samples of PBMCs and plasma from 26 patients infected with HIV-1 were obtained during 20 consecutive months for the measurement of VL, viral DNA and mRNA burdens, and CD4 positive (CD4+) cells count. The quantitative polymerase chain reaction (PCR) method with detection by solid phase DNA was utilized for the assay of VL, viral DNA and mRNA burdens.

RESULTS

Eighty-six VL, 101 viral mRNA and 129 viral DNA out of 131 samples were detected. There was a significant positive correlation between VL and the viral mRNA burden (r = 0.600, P < or = 0.001), and between VL and the viral DNA burden (r = 0.368, P < or = 0.001). Focused on individuals, the viral mRNA burdens varied in a manner relatively dependent on VL when both values were detectable. However, viral DNA burdens varied relatively independently of VL and the viral mRNA burdens. In six patients the viral mRNA burden was detectable and changed even if the VL was undetectable throughout the observation period.

CONCLUSIONS

Both viral DNA and viral mRNA burdens still showed detectable changes even when the VLs became undetectable in most patients. The measurement of viral mRNA or DNA burdens may be clinically available to identify viral replication when VL is undetectable.

摘要

目的

为明确人类免疫缺陷病毒1型(HIV-1)感染患者的病毒学状态,我们比较了血浆HIV-1 RNA拷贝数(血浆病毒载量(VL))、外周血单个核细胞(PBMC)中的病毒DNA和mRNA载量,以及其他临床预测指标。

方法

在连续20个月内,从26例HIV-1感染患者中获取了131份PBMC和血浆样本,用于检测VL、病毒DNA和mRNA载量以及CD4阳性(CD4+)细胞计数。采用固相DNA检测的定量聚合酶链反应(PCR)方法检测VL、病毒DNA和mRNA载量。

结果

131份样本中检测到86份VL、101份病毒mRNA和129份病毒DNA。VL与病毒mRNA载量之间存在显著正相关(r = 0.600,P≤0.001),VL与病毒DNA载量之间也存在显著正相关(r = 0.368,P≤0.001)。就个体而言,当两者均可检测到时,病毒mRNA载量的变化方式相对依赖于VL。然而,病毒DNA载量的变化相对独立于VL和病毒mRNA载量。在6例患者中,即使在整个观察期内VL均未检测到,病毒mRNA载量仍可检测到且发生了变化。

结论

即使在大多数患者中VL变得无法检测到时,病毒DNA和病毒mRNA载量仍显示出可检测到的变化。当VL无法检测到时,测量病毒mRNA或DNA载量在临床上可能有助于识别病毒复制情况。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验